Zhejiang Starry Pharmaceutical Co.,Ltd. (SHA:603520)
China · Delayed Price · Currency is CNY 9.02
-0.23 (-2.49%)
Jun 11, 2026, 11:29 AM CST
SHA:603520 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 16.84 | 10.23 | -49.1 | 44.23 | -75.85 | 323.75 |
Depreciation & Amortization | 238.73 | 238.73 | 222.17 | 179.55 | 160.44 | 154.97 |
Other Amortization | 7.5 | 7.5 | 5.72 | 6.5 | 8.53 | 4.16 |
Loss (Gain) From Sale of Assets | -0.45 | -0.45 | -0.01 | -3.53 | 0.35 | 4.34 |
Asset Writedown & Restructuring Costs | 8.74 | 8.74 | 13.72 | 4.34 | 117.79 | -0.32 |
Loss (Gain) From Sale of Investments | 7.53 | 7.53 | 6.69 | 10.3 | -11.67 | -7.39 |
Provision & Write-off of Bad Debts | 9.23 | 9.23 | -1.87 | -10.61 | 0.14 | 13.1 |
Other Operating Activities | -69.99 | 93.82 | 134.17 | 125.66 | 133.98 | 80.8 |
Change in Accounts Receivable | -204.63 | -204.63 | -359.66 | 160.47 | -187.88 | -349.61 |
Change in Inventory | -137.28 | -137.28 | -2.19 | -465.85 | -281.59 | -9.52 |
Change in Accounts Payable | -27.47 | -27.47 | 238.67 | -5.96 | 58.93 | 292.64 |
Change in Other Net Operating Assets | 4.52 | 4.52 | 0.42 | 0.04 | 5.19 | 10.83 |
Operating Cash Flow | -153.53 | 3.67 | 193.5 | 44.55 | -78.37 | 508.84 |
Operating Cash Flow Growth | - | -98.11% | 334.33% | - | - | 191.63% |
Capital Expenditures | -245.75 | -269.2 | -480.62 | -266.22 | -472.18 | -303.88 |
Sale of Property, Plant & Equipment | 2.72 | 2.72 | 1.27 | 18.88 | 1.68 | 7.25 |
Cash Acquisitions | - | - | - | - | - | -21.71 |
Divestitures | 0.01 | 0.01 | - | - | 30.93 | - |
Investment in Securities | 7.55 | - | -11.3 | -8.22 | 110.25 | 36.06 |
Other Investing Activities | 0.17 | - | -0.09 | 1.57 | -2.9 | - |
Investing Cash Flow | -235.3 | -266.47 | -490.74 | -253.99 | -332.22 | -282.28 |
Long-Term Debt Issued | - | 2,523 | 2,064 | 2,851 | 2,069 | 1,208 |
Long-Term Debt Repaid | - | -2,212 | -2,571 | -2,562 | -1,228 | -1,393 |
Net Debt Issued (Repaid) | 293.55 | 311.42 | -506.72 | 288.84 | 840.13 | -184.68 |
Issuance of Common Stock | - | - | 934.98 | - | - | 3.4 |
Repurchase of Common Stock | - | - | - | -10.18 | -2.85 | -1.41 |
Common Dividends Paid | -143.22 | -145.98 | -128.42 | -195.65 | -217.6 | -201 |
Other Financing Activities | 152.97 | -11.36 | -0.81 | - | -256.1 | 81.9 |
Financing Cash Flow | 303.29 | 154.08 | 299.03 | 83.01 | 363.58 | -301.79 |
Foreign Exchange Rate Adjustments | 22.42 | 23.86 | -20.7 | 0.82 | 11.51 | 0.24 |
Net Cash Flow | -63.11 | -84.86 | -18.91 | -125.61 | -35.5 | -74.99 |
Free Cash Flow | -399.28 | -265.53 | -287.12 | -221.67 | -550.56 | 204.96 |
Free Cash Flow Growth | - | - | - | - | - | 861.68% |
Free Cash Flow Margin | -16.16% | -10.86% | -12.22% | -10.09% | -25.83% | 10.25% |
Free Cash Flow Per Share | -0.80 | -0.52 | -0.70 | -0.65 | -1.60 | 0.59 |
Cash Income Tax Paid | - | -12.67 | -7.45 | -51.86 | 43.99 | 86.16 |
Levered Free Cash Flow | -413.27 | -402.57 | -160.43 | -283.69 | -639.09 | -100.76 |
Unlevered Free Cash Flow | -363.81 | -353.11 | -100.33 | -219.56 | -581.22 | -54.62 |
Change in Working Capital | -371.66 | -371.66 | -137.99 | -311.89 | -412.08 | -64.58 |